Sibionics Loses 2nd Bid At Nixing Abbott Patent
Europe's patent court has granted Abbott Diabetes exclusive rights over a glucose monitoring device that can be fitted in a single step, rejecting claims from a Sibionics unit that earlier devices...To view the full article, register now.
Already a subscriber? Click here to view full article